VERNON TAYLOR: Open Payments
NPI 1326380304 · GRAY, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$812 in 56 payments from 10 companies in 2025. Trend: 2023 $1,093 · 2024 $1,201 · 2025 $812
Food & beverage: $812
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 11 | $149 |
| AstraZeneca Pharmaceuticals LP | 6 | $145 |
| ABBVIE INC. | 15 | $140 |
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $138 |
| Novo Nordisk Inc | 6 | $97 |
| Amgen Inc. | 4 | $64 |
| Vanda Pharmaceuticals Inc. | 2 | $29 |
| Xeris Pharmaceuticals, Inc. | 1 | $21 |
| Indivior Inc. | 1 | $15 |
| PFIZER INC. | 1 | $14 |
Products named: Kerendia, QULIPTA, MOUNJARO, JARDIANCE, Wegovy, Rybelsus, EVENITY, VRAYLAR.
Industry payments across KY — which companies pay providers there.
